Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Matthew
Matt attended UT Dallas on a full-ride McDermott Scholarship, where he earned his BS in Mathematics (summa cum laude). He went on to earn his Master's in Global Affairs as a Schwarzman Scholar at Tsinghua University.
Anna
Anna holds a PhD in Slavic Languages and Literature (Harvard), an MA in Slavic Languages and Literature (MA), a BA in History and Philology (Russian State University) and a BA in Fine Arts (Pushkin State Museum Art College).